3844-54-0|Methyl L-norleucinate hydrochloride

Current Location
Home Products
detail

Methyl L-norleucinate hydrochloride | CAS:3844-54-0

Methyl L-norleucinate hydrochloride

Name：Methyl L-norleucinate hydrochloride
CAS：3844-54-0
Synonyms：(S)-2-Aminohexanoic acid methyl ester hydrochloride; Methyl (2S)-2-aminohexanoate hydrochloride
Molecular Formula：C₇H₁₅NO₂.HCl
Molecular Weight：181.66
EINESC：

Description

Properties

Melting point	131-132 ºC*

Safety

没有数据	没有数据

SDS

Source	SDS/MSDS Samples
没有数据	没有数据

Synthetic Route

Name	CAS

Articles

Peer-Reviewed Papers

p-Fluorophenylglycine in the urine of baboons treated with HPTP, the tetrahydropyridine analog of haloperidol.L J Mienie et al.Life sciences, 65(5), 535-542 (1999-08-26) Uptake of 6-[18F]fluoro-L-dopa and [18F]CFT reflect nigral neuronal loss in a rat model of Parkinson's disease.Sarita Forsback et al.Synapse (New York, N.Y.), 51(2), 119-127 (2003-11-18) Tissue distribution studies of [18F]haloperidol, [18F]-beta-(4-fluorobenzoyl)propionic acid, and [82Br]bromperidol by external scintigraphy.G A Digenis et al.Journal of pharmaceutical sciences, 70(9), 985-989 (1981-09-01) Role of CYP3A in bromperidol metabolism in rat in vitro and in vivo.M Watanabe et al.Xenobiotica; the fate of foreign compounds in biological systems, 29(8), 839-846 (1999-12-20) Identification of a new functional target of haloperidol metabolite: implications for a receptor-independent role of 3-(4-fluorobenzoyl) propionic acid.Hyeon Soo Kim et al.Journal of neurochemistry, 99(2), 458-469 (2006-10-13) CYP3A is responsible for N-dealkylation of haloperidol and bromperidol and oxidation of their reduced forms by human liver microsomes.T Tateishi et al.Life sciences, 67(24), 2913-2920 (2001-01-02) Role of CYP3A in haloperidol N-dealkylation and pharmacokinetics in rats.M Watanabe et al.Fundamental & clinical pharmacology, 13(3), 337-342 (1999-07-07) Antagonism by haloperidol and its metabolites of mechanical hypersensitivity induced by intraplantar capsaicin in mice: role of sigma-1 receptors.José M Entrena et al.Psychopharmacology, 205(1), 21-33 (2009-03-28)

Remarks

Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.

Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).

Name	CAS

Description

Properties

Safety

SDS

Related Products

Related News